Currently accepted at: JMIR Medical Informatics
Date Submitted: Mar 24, 2026
Date Accepted: Nov 12, 2026
This paper has been accepted and is currently in production.
It will appear shortly on 10.2196/95960
The final accepted version (not copyedited yet) is in this tab.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
A Rule-Based decision support system (DSS) for safe and personalized physical exercise prescription in Cardiac Rehabilitation: Design, methodology, and validation.
ABSTRACT
Background:
Exercise-based cardiac rehabilitation (CR) is a class A recommendation for patients with cardiovascular disease. While structured physical exercise prescription is usually well supported during inpatient and center-based rehabilitation, long-term exercise management specifically during Phase III CR remains difficult to deliver since his phase requires sustained follow-up and repeated, individualized adaptation of exercise programs. In practice, clinicians must apply complex and sometimes overlapping guideline recommendations to heterogeneous patients, often with limited time and specialist support. Existing digital tools support parts of this process, but structured, supervised week-by-week exercise progression integrated into everyday clinical workflows remains challenging to implement consistently. This study aimed to develop and assess the feasibility and perceived clinical acceptability of an end-to-end decision support framework for Phase III CR.
Objective:
The specific aim of this study was to develop and evaluate the feasibility, safety, and perceived clinical acceptability of a rule-based decision support system, the Rule-Based Exercise Prescription Tool (REPT), designed to provide end-to-end, guideline-based exercise prescription and progression for patients in Cardiac Rehabilitation, facilitating structured, supervised, and individualized exercise management within routine clinical workflows.
Methods:
We developed the Rule-Based Exercise Prescription Tool (REPT), a clinical decision support system that integrates guideline-based exercise goal assessment with weekly exercise prescription and progression. Guideline recommendations were formalized as transparent, traceable rules using a conservative safety-first conflict resolution strategy. Appropriateness and feasibility was evaluated using simulated patient cases (n=12) in two phases: internal stakeholder feedback and an external evaluation with general practitioners (n=33). Outcomes included perceived guideline compliance, safety, usefulness, feasibility, and acceptability.
Results:
We extracted and integrated 112 actionable rules and developed a progression algorithm for exercise prescription. In phase 1 internal testing, clinicians rated 95% of generated exercise permissibility reports and initial exercise programs as safe and guideline consistent. In phase 2, general practitioners accepted 79% of weekly exercise prescriptions and progression scenarios without modification, requested minor adjustments in 19% of cases, and rejected 2%. Overall perceived usefulness was high, and more than 90% of clinicians rated the system as useful or very useful for both decision support and educational purposes.
Conclusions:
The developed solution represents a feasible tool of an end-to-end decision support framework for exercise prescription in CR, supporting structured, supervised exercise management over time. Further real-world evaluation is needed to assess usability in routine practice and clinical impact.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.